Early research (Phase 1)Study completedNCT05078879
What this trial is testing
Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency
Who this might be right for
Crohn's DiseaseGlycogen MetabolismInflammatory Bowel Disease (IBD)
National Institute of Allergy and Infectious Diseases (NIAID) 4